TY - VIDEO
KW - Opioid abuse -- Treatment -- Alaska
KW - Naloxone -- Therapeutic use -- Alaska
KW - Buprenorphine -- Therapeutic use -- Alaska
KW - Narcotic antagonists -- Therapeutic use -- Alaska
KW - Buprenorphine -- Therapeutic Use
KW - Dissertations, Academic
KW - Opioid abuse -- Treatment
KW - University of Alaska Fairbanks -- Dissertations -- 2020
KW - University of Alaska Fairbanks
KW - Alaska
KW - Thesis/dissertation (deg)
KW - Manuscript (mss)
AU - Ángel Vasquez
A1 - 
C4 - This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
C5 - Grey Literature; Healthcare Disparities; Opioids & Substance Use
LA - English
M1 - Dissertation/Thesis
PB - University of Alaska Fairbanks
PY - 2020
RN - https://scholarworks.alaska.edu/handle/11122/12323
T1 - In pursuit of harm reduction in the Alaskan context : patient cultural explanatory models of addiction and treatment outcomes for a medically-assisted program utilizing a buprenorphine/naloxone formulation
TI - In pursuit of harm reduction in the Alaskan context : patient cultural explanatory models of addiction and treatment outcomes for a medically-assisted program utilizing a buprenorphine/naloxone formulation
U1 - Grey Literature; Healthcare Disparities; Opioids & Substance Use
U4 - This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
U5 - https://scholarworks.alaska.edu/handle/11122/12323
Y1 - 2020
ER -